Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ilse K. Luirink"'
Autor:
Eva S. Peper, Gustav J. Strijkers, Katja Gazzola, Wouter V. Potters, Abdallah G. Motaal, Ilse K. Luirink, Barbara A. Hutten, Albert Wiegman, Pim van Ooij, Bert-Jan H. van den Born, Aart J. Nederveen, Bram F. Coolen
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 20, Iss 1, Pp 1-12 (2018)
Abstract Background Cardiovascular magnetic resonance (CMR) allows for non-invasive assessment of arterial stiffness by means of measuring pulse wave velocity (PWV). PWV can be calculated from the time shift between two time-resolved flow curves acqu
Externí odkaz:
https://doaj.org/article/ea28abab5fb94f77b4d4acff85ea18ba
Autor:
Eva M.M. Hoytema van Konijnenburg, Ilse K. Luirink, Sebastian E.E. Schagen, Marc Engelen, Kevin Berendse, Bwee Tien Poll-The, Malika Chegary
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 23, Iss , Pp - (2020)
Externí odkaz:
https://doaj.org/article/52fbed6771b643089ad345807f92c836
Autor:
Francisco J Nóvoa, Claus Peter Schmitt, Sarah D. de Ferranti, Genovefa Kolovou, Lars Pape, Ilse K. Luirink, Barbara A. Hutten, Christina Taylan, Awad Shahrani, Jaap W. Groothoff, Albert Wiegman, Michel Farnier, Jun Oh, Luis Masana, Susanne Greber-Platzer, Martin Maeser, Samir Saheb, Eric Bruckert, Joenna Driemeyer, Eldad J. Dann
Publikováno v:
Atherosclerosis, 299, 24-31. Elsevier Ireland Ltd
Background and aims: Homozygous familial hypercholesterolemia (hoFH) may cause life-threatening atherosclerotic cardiovascular disease in childhood. Lipoprotein apheresis (LA) is considered a pivotal treatment option, but data on its efficacy, safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7db093be8f2874096be25398cb1ef5f4
https://doi.org/10.1016/j.atherosclerosis.2020.01.031
https://doi.org/10.1016/j.atherosclerosis.2020.01.031
Autor:
Kika van Bergen en Henegouwen, Barbara A. Hutten, Ilse K. Luirink, Albert Wiegman, Eric de Groot, D. Meeike Kusters
Publikováno v:
van Bergen en Henegouwen, K, Hutten, B A, Luirink, I K, Wiegman, A, de Groot, E & Kusters, D M 2022, ' Intima-media thickness in treated and untreated patients with and without familial hypercholesterolemia : A systematic review and meta-analysis ', Journal of clinical lipidology, vol. 16, no. 2, pp. 128-142 . https://doi.org/10.1016/j.jacl.2022.01.009
Familial hypercholesterolemia (FH) is a common genetic disorder of lipoprotein metabolism leading to premature atherosclerosis. From early onset, status and progression of atherosclerosis of the large peripheral arterial walls can be quantified by ul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd55917f196114b9d8307cf1b369d58e
https://pubmed.ncbi.nlm.nih.gov/35184975
https://pubmed.ncbi.nlm.nih.gov/35184975
Autor:
Claus Peter Schmitt, Albert Wiegman, Eric Bruckert, Ilse K. Luirink, Jim Determeijer, Jaap W. Groothoff, Barbara A. Hutten
Publikováno v:
Journal of clinical lipidology, 13(1), 31-39. Elsevier BV
Background: Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder that may cause life-threatening cardiovascular disease (CVD) at childhood. Marginal effectiveness of statins in reducing low-density lipoprotein cholesterol (LDL-C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dc4e996cda4bbd27b442ae673c66654
https://doi.org/10.1016/j.jacl.2018.10.011
https://doi.org/10.1016/j.jacl.2018.10.011
Autor:
Roel S. Driessen, G. Kees Hovingh, Nick S. Nurmohamed, Erik S.G. Stroes, Laurens F. Reeskamp, Michiel J. Bom, Pepijn A. van Diemen, Ilse K. Luirink, Jaap W. Groothoff, Paul Knaapen, R. Nils Planken, Albert Wiegman, Irene M. Kuipers
Publikováno v:
Atherosclerosis, 327, 13-17. Elsevier Ireland Ltd
Reeskamp, L F, Nurmohamed, N S, Bom, M J, Planken, R N, Driessen, R S, van Diemen, P A, Luirink, I K, Groothoff, J W, Kuipers, I M, Knaapen, P, Stroes, E S G, Wiegman, A & Hovingh, G K 2021, ' Marked plaque regression in homozygous familial hypercholesterolemia ', Atherosclerosis, vol. 327, pp. 13-17 . https://doi.org/10.1016/j.atherosclerosis.2021.04.014
Reeskamp, L F, Nurmohamed, N S, Bom, M J, Planken, R N, Driessen, R S, van Diemen, P A, Luirink, I K, Groothoff, J W, Kuipers, I M, Knaapen, P, Stroes, E S G, Wiegman, A & Hovingh, G K 2021, ' Marked plaque regression in homozygous familial hypercholesterolemia ', Atherosclerosis, vol. 327, pp. 13-17 . https://doi.org/10.1016/j.atherosclerosis.2021.04.014
Background and aims Both plasma low-density lipoprotein (LDL) cholesterol levels and risk for premature cardiovascular disease are extremely elevated in patients with homozygous familial hypercholesterolemia (HoFH), despite the use of multiple choles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4ed8484c8c049157cc83e7a1bcaf372
https://pubmed.ncbi.nlm.nih.gov/34004483
https://pubmed.ncbi.nlm.nih.gov/34004483
Autor:
Ilse K. Luirink, Eva M. M. Hoytema van Konijnenburg, Sebastian E.E. Schagen, Bwee Tien Poll-The, Malika Chegary, Kevin Berendse, Marc Engelen
Publikováno v:
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports, Vol 23, Iss, Pp-(2020)
Molecular genetics and metabolism reports, 23:100590. Elsevier BV
Molecular Genetics and Metabolism Reports, Vol 23, Iss, Pp-(2020)
Molecular genetics and metabolism reports, 23:100590. Elsevier BV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc6b0e2d968a9c0177e6d9ba80236298
https://pubmed.ncbi.nlm.nih.gov/32373468
https://pubmed.ncbi.nlm.nih.gov/32373468
Autor:
Min-Ji Charng, Evan A. Stein, Flemming Skovby, Daniel Gaudet, Mafauzy Mohamed, Etienne Sokal, Mattias Sundén, Joel S. Raichlen, Frederick J. Raal, Stefan Carlsson, John J.P. Kastelein, Albert Wiegman, Ilse K. Luirink, Eldad J. Dann
Publikováno v:
Journal of the American College of Cardiology, 70(9), 1162-1170. Elsevier USA
BACKGROUND Homozygous familial hypercholesterolemia (HoFH), a rare genetic disorder, is characterized by extremely elevated levels of low-density lipoprotein cholesterol (LDL-C) and accelerated atherosclerotic cardiovascular disease. Statin treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::789bef86c080e55d4355ab5fff583b10
https://doi.org/10.1016/j.jacc.2017.06.058
https://doi.org/10.1016/j.jacc.2017.06.058
Autor:
Irene M. Kuipers, Ilse K. Luirink, Jaap W. Groothoff, Barbara A. Hutten, Adrianus P.C.M. Backx, Albert Wiegman, R. N. Planken
Publikováno v:
Atherosclerosis, 285, 87-92. Elsevier Ireland Ltd
Background and aims Homozygous familial hypercholesterolemia (hoFH) is a rare genetic disease, hallmarked by a lifelong exposure to very high levels of low-density lipoprotein cholesterol (LDL-C). Untreated, patients can experience a cardiovascular e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca38a36386c7db5a85074cda39a30207
https://research.vumc.nl/en/publications/d0be070b-bc5b-4efd-a97d-f399ef62056d
https://research.vumc.nl/en/publications/d0be070b-bc5b-4efd-a97d-f399ef62056d
Autor:
Michel H. Hof, D Meeike Kusters, Albert Wiegman, John J.P. Kastelein, Jaap W. Groothoff, Ilse K. Luirink, Barbara A. Hutten, Eric de Groot
Publikováno v:
New England journal of medicine, 381(16), 1547-1556. Massachussetts Medical Society
BACKGROUND Familial hypercholesterolemia is characterized by severely elevated low-density lipoprotein (LDL) cholesterol levels and premature cardiovascular disease. The short-term efficacy of statin therapy in children is well established, but longe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::237c389aaf1f2e5f35d14aeac0855688
https://pure.amc.nl/en/publications/20year-followup-of-statins-in-children-with-familial-hypercholesterolemia(2535c769-ca9d-4593-9c20-2dd51c470513).html
https://pure.amc.nl/en/publications/20year-followup-of-statins-in-children-with-familial-hypercholesterolemia(2535c769-ca9d-4593-9c20-2dd51c470513).html